跳至主要内容
临床试验/NCT03161704
NCT03161704已完成不适用

Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol

Yale University5 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2016年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
114
试验地点
5
主要终点
Collection of up to 3 2cm samples of Endometrial Tissue

研究概览

简要总结

This study involves the prospective collection of endometrial biopsy tissue, serum, plasma, whole blood for DNA extraction, and urine from women who will be diagnosed as having (or not having) endometriosis at the time of scheduled surgery. The investigators plan to enroll approximately 500 women to validate and optimize the use of genomic classifiers alone or in combination with serum markers (such as cytokines) as a non-surgical marker of disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-44 scheduled to undergo gynecologic surgery (laparoscopy/laparotomy).
  • Indication for surgery can include: infertility, endometriosis, tubal ligation, lysis of adhesions, pelvic pain, hysterectomy (for benign condition), myomectomy, salpingo-oophorectomy, cystectomy, or diagnostic laparoscopy.

排除标准

  • 未提供

结局指标

主要结局

Collection of up to 3 2cm samples of Endometrial Tissue

时间窗: 2 collection timepoints: baseline and up to 18 weeks following surgery.

Up to 3 2cm samples will be collected per collection.

次要结局

  • Collection of Serum 2 will be 2 7 ml serum tubes of serum(3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.)
  • Collection of Serum 1 will be 2 10ml serum tubes of serum(3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验